{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T11:20:08Z","timestamp":1769426408987,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Topics in Companion Animal Medicine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1053\/j.tcam.2012.08.002","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T09:16:34Z","timestamp":1348996594000},"page":"88-94","source":"Crossref","is-referenced-by-count":36,"title":["Antithrombotic Therapy"],"prefix":"10.1053","volume":"27","author":[{"given":"Stephanie Ann","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.tcam.2012.08.002_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.tcam.2012.07.002","article-title":"Diseases associated with thrombosis","volume":"27","author":"de Laforcade","year":"2012","journal-title":"Top Companion Anim Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib2","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"issue":"suppl 1","key":"10.1053\/j.tcam.2012.08.002_bib3","first-page":"103","article-title":"Heparin\/low molecular weight heparin and tissue factor pathway inhibitor","volume":"23","author":"Abildgaard","year":"1993","journal-title":"Haemostasis"},{"issue":"suppl 1","key":"10.1053\/j.tcam.2012.08.002_bib4","first-page":"107","article-title":"Is tissue factor pathway inhibitor involved in the antithrombotic effect of heparins?","volume":"23","author":"Ostergaard","year":"1993","journal-title":"Haemostasis"},{"key":"10.1053\/j.tcam.2012.08.002_bib5","series-title":"Schalm's Veterinary Hematology","first-page":"635","article-title":"Overview of hemostasis","author":"Smith","year":"2010"},{"issue":"207","key":"10.1053\/j.tcam.2012.08.002_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-23056-1_8","article-title":"Heparin and heparan sulfate: analyzing structure and microheterogeneity","author":"Shriver","year":"2012","journal-title":"Handb Exp Pharmacologist"},{"issue":"suppl 1","key":"10.1053\/j.tcam.2012.08.002_bib7","first-page":"77","article-title":"Are the available low-molecular-weight heparin preparations the same?","volume":"22","author":"Fareed","year":"1996","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.tcam.2012.08.002_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/s-2004-861513","article-title":"Generic low-molecular-weight heparins: some practical considerations","volume":"30","author":"Fareed","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.tcam.2012.08.002_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/13543784.11.3.397","article-title":"Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent","volume":"11","author":"Walenga","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1053\/j.tcam.2012.08.002_bib10","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.ATV.17.8.1568","article-title":"Induction of the acute-phase reaction increases heparin-binding proteins in plasma","volume":"17","author":"Young","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.tcam.2012.08.002_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1939-1676.2007.tb02979.x","article-title":"Anticoagulant effects of low-molecular-weight heparins in healthy cats","volume":"21","author":"Alwood","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2460\/ajvr.1982.43.08.1473","article-title":"Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats","volume":"43","author":"Greene","year":"1982","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib13","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2460\/ajvr.2001.62.1887","article-title":"Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs","volume":"62","author":"Mischke","year":"2001","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/rvsc.2000.0447","article-title":"The monitoring of heparin administration by screening tests in experimental dogs","volume":"70","author":"Mischke","year":"2001","journal-title":"Res Vet Sci"},{"key":"10.1053\/j.tcam.2012.08.002_bib15","first-page":"187","article-title":"Determining and monitoring of a therapeutic heparin dosage in the dog [abstract]","volume":"9","author":"Kellerman","year":"1995","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1939-1676.2010.0505.x","article-title":"Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs","volume":"24","author":"Helmond","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5326\/0450125","article-title":"A prospective study of unfractionated heparin therapy in dogs with primary immune-mediated hemolytic anemia","volume":"45","author":"Breuhl","year":"2009","journal-title":"J Am Anim Hosp Assoc"},{"issue":"suppl 3","key":"10.1053\/j.tcam.2012.08.002_bib18","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/S0049-3848(11)70027-5","article-title":"Overview on guidelines and recommendations for generic low-molecular-weight heparins","volume":"127","author":"Harenberg","year":"2011","journal-title":"Thromb Res"},{"issue":"suppl 3","key":"10.1053\/j.tcam.2012.08.002_bib19","first-page":"51","article-title":"Pharmacokinetics of low molecular weight heparins in animal models","volume":"25","author":"Fareed","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.tcam.2012.08.002_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-60761-803-4_3","article-title":"Heparin and low-molecular weight heparins in thrombosis and beyond","volume":"663","author":"Mousa","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.tcam.2012.08.002_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1939-1676.2009.0412.x","article-title":"Antithrombotic effect of enoxaparin in clinically healthy cats: a venous stasis model","volume":"24","author":"Van De Wiele","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1008806312396","article-title":"Effects of intravenous Enoxaparin and intravenous Inogatran in an electrolytic injury model of venous thrombosis in the dog","volume":"6","author":"Ignasiak","year":"1998","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.tcam.2012.08.002_bib23","first-page":"132","article-title":"The effect of a low molecular weight heparin on coagulation parameters in healthy cats","volume":"73","author":"Vargo","year":"2009","journal-title":"Can J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2460\/ajvr.2001.62.595","article-title":"Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs","volume":"62","author":"Mischke","year":"2001","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0049-3848(99)00094-8","article-title":"Laboratory monitoring of pentasaccharide in a dog model of hemodialysis","volume":"96","author":"Hoppensteadt","year":"1999","journal-title":"Thromb Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/104063870301500615","article-title":"Heparin in vitro sensitivity of the activated partial thromboplastin time in canine plasma depends on reagent","volume":"15","author":"Mischke","year":"2003","journal-title":"J Vet Diagn Invest"},{"key":"10.1053\/j.tcam.2012.08.002_bib27","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cvsm.2003.08.003","article-title":"Immune-mediated hemolytic anemia: understanding the nemesis","volume":"33","author":"McCullough","year":"2003","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1053\/j.tcam.2012.08.002_bib28","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2460\/ajvr.1985.46.07.1460","article-title":"Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog","volume":"46","author":"Hellebrekers","year":"1985","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1939-165X.2004.tb00375.x","article-title":"Evaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasma","volume":"33","author":"Brooks","year":"2004","journal-title":"Vet Clin Pathol"},{"key":"10.1053\/j.tcam.2012.08.002_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/rvsc.2000.0418","article-title":"The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin","volume":"69","author":"Mischke","year":"2000","journal-title":"Res Vet Sci"},{"key":"10.1053\/j.tcam.2012.08.002_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1939-165X.2008.00068.x","article-title":"In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time","volume":"37","author":"Jessen","year":"2008","journal-title":"Vet Clin Pathol"},{"key":"10.1053\/j.tcam.2012.08.002_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2460\/ajvr.73.6.789","article-title":"Correlation of hematocrit, platelet concentration, and plasma coagulation factors with results of thromboelastometry in canine whole blood samples","volume":"73","author":"Smith","year":"2012","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib33","first-page":"1","article-title":"Adjustment of intermittent subcutaneous heparin therapy based on chromogenic heparin assay in 9 cats with thromboembolism [abstract]","volume":"12","author":"Smith","year":"1998","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.rvsc.2004.10.006","article-title":"Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation","volume":"79","author":"Mischke","year":"2005","journal-title":"Res Vet Sci"},{"key":"10.1053\/j.tcam.2012.08.002_bib35","first-page":"231","article-title":"Determination of a therapeutic heparin dosage in the cat [abstract]","volume":"10","author":"Kellerman","year":"1996","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1939-1676.1999.tb02192.x","article-title":"Pulmonary thromboembolism in 29 dogs: 1985-1995","volume":"13","author":"Johnson","year":"1999","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib37","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2460\/javma.2005.226.1869","article-title":"Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)","volume":"226","author":"Weinkle","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"10.1053\/j.tcam.2012.08.002_bib38","first-page":"389","article-title":"Prednisone and cyclosporine vs prednisone alone for treatment of canine immune-mediated hemolytic anemia (IMHA) [abstract]","volume":"18","author":"Husbands","year":"2004","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib39","doi-asserted-by":"crossref","first-page":"337S","DOI":"10.1378\/chest.102.4_Supplement.337S","article-title":"Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"102","author":"Hirsh","year":"1992","journal-title":"Chest"},{"key":"10.1053\/j.tcam.2012.08.002_bib40","first-page":"73","article-title":"Arterial thromboembolism in cats: acute crisis in 127 cases (1992-2001) and long-term management with low-dose aspirin in 24 cases","volume":"17","author":"Smith","year":"2003","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jfms.1999.0049","article-title":"Feline distal aortic thromboembolism: a review of 44 cases (1990-1998)","volume":"1","author":"Schoeman","year":"1999","journal-title":"J Feline Med Surg"},{"key":"10.1053\/j.tcam.2012.08.002_bib42","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1053\/j.tcam.2012.08.002_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2885.1981.tb00722.x","article-title":"Warfarin in the dog: pharmacokinetics as related to clinical response","volume":"4","author":"Neff-Davis","year":"1981","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1053\/j.tcam.2012.08.002_bib44","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cvsm.2004.05.006","article-title":"Feline arterial thromboembolism: an update","volume":"34","author":"Smith","year":"2004","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1053\/j.tcam.2012.08.002_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2885.2000.00269.x","article-title":"Plasma pharmacokinetics of warfarin enantiomers in cats","volume":"23","author":"Smith","year":"2000","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1053\/j.tcam.2012.08.002_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2885.2000.00268.x","article-title":"Pharmacodynamics of warfarin in cats","volume":"23","author":"Smith","year":"2000","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1053\/j.tcam.2012.08.002_bib47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jvc.2012.02.008","article-title":"Aortic thrombosis in dogs: presentation, therapy, and outcome in 26 cases","volume":"14","author":"Winter","year":"2012","journal-title":"J Vet Cardiol"},{"key":"10.1053\/j.tcam.2012.08.002_bib48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.108.025569","article-title":"Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans","volume":"37","author":"Weinz","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1053\/j.tcam.2012.08.002_bib49","first-page":"776","article-title":"In vitro evaluation of the effect of rivaroxaban on coagulation parameters in healthy dogs [abstract]","volume":"26","author":"Conversy","year":"2012","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib50","first-page":"697","article-title":"In vitro effects of rivaroxaban on feline coagulation indices [abstract]","volume":"25","author":"Brainard","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0967-2109(98)00119-7","article-title":"Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model","volume":"7","author":"Sakai","year":"1999","journal-title":"Cardiovasc Surg"},{"key":"10.1053\/j.tcam.2012.08.002_bib52","series-title":"Platelets","first-page":"1099","article-title":"Aspirin","author":"Awtry","year":"2007"},{"key":"10.1053\/j.tcam.2012.08.002_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2460\/ajvr.68.3.251","article-title":"Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs","volume":"68","author":"Brainard","year":"2007","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1939-165X.2007.tb00222.x","article-title":"Platelet function in dogs: breed differences and effect of acetylsalicylic acid administration","volume":"36","author":"Nielsen","year":"2007","journal-title":"Vet Clin Pathol"},{"key":"10.1053\/j.tcam.2012.08.002_bib55","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1939-1676.2011.00781.x","article-title":"Platelet cyclooxygenase expression in normal dogs","volume":"25","author":"Thomason","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2460\/ajvr.71.3.349","article-title":"Effects of aspirin, carprofen, deracoxib, and meloxicam on platelet function and systemic prostaglandin concentrations in healthy dogs","volume":"71","author":"Blois","year":"2010","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib57","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2460\/ajvr.71.11.1294","article-title":"Influence of treatment with ultralow-dose aspirin on platelet aggregation as measured by whole blood impedance aggregometry and platelet P-selectin expression in clinically normal dogs","volume":"71","author":"Sharpe","year":"2010","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib58","first-page":"745","article-title":"Effects of aspirin and clopidogrel on platelet function in healthy dogs [abstract]","volume":"23","author":"Shearer","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib59","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2460\/ajvr.72.8.1038","article-title":"Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs","volume":"72","author":"Hoh","year":"2011","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib60","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1939-1676.2006.tb02915.x","article-title":"Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia","volume":"20","author":"Weiss","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cvsm.2007.01.010","article-title":"Thromboembolic therapies in dogs and cats: an evidence-based approach","volume":"37","author":"Lunsford","year":"2007","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1053\/j.tcam.2012.08.002_bib62","first-page":"693","article-title":"Comparison of individually monitored unfractionated heparin versus low-dose aspirin on survival of dogs with immune mediated hemolytic anemia [abstract]","volume":"23","author":"Orcutt","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib63","series-title":"Platelets","first-page":"1127","article-title":"ADP Receptor Antagonists","author":"Cattaneo","year":"2007"},{"key":"10.1053\/j.tcam.2012.08.002_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0049-3848(82)90157-8","article-title":"A new in vivo model of arterial thrombosis: the effect of administration of ticlopidine and verapamil in dogs","volume":"28","author":"Pumphrey","year":"1982","journal-title":"Thromb Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib65","first-page":"178","article-title":"Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts","volume":"104","author":"Valentin","year":"1988","journal-title":"Surgery"},{"key":"10.1053\/j.tcam.2012.08.002_bib66","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2460\/ajvr.2004.65.327","article-title":"Evaluation of antiplatelet effects of ticlopidine in cats","volume":"65","author":"Hogan","year":"2004","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib67","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2460\/ajvr.1991.52.12.2000","article-title":"Effects of treatment with ticlopidine in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs","volume":"52","author":"Boudreaux","year":"1991","journal-title":"Am J Vet Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib68","first-page":"887","article-title":"A comparison of ticlopidine and heparin on hemodialysis in dogs","volume":"100","author":"Gross","year":"1982","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib69","first-page":"609","article-title":"The pharmacodynamics of clopidogrel in the dog [abstract]","volume":"21","author":"Goodwin","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib70","first-page":"609","article-title":"Altered hepatic metabolism of clopidogrel in dogs with inducers and inhibitors of hepatic enzymes [abstract]","volume":"21","author":"Goodwin","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib71","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2460\/javma.2004.225.1406","article-title":"Antiplatelet effects and pharmacodynamics of clopidogrel in cats","volume":"225","author":"Hogan","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"10.1053\/j.tcam.2012.08.002_bib72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","article-title":"Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis","volume":"154","author":"Snoep","year":"2007","journal-title":"Am Heart J"},{"key":"10.1053\/j.tcam.2012.08.002_bib73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.thromres.2008.10.007","article-title":"Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent","volume":"124","author":"Wang","year":"2009","journal-title":"Thromb Res"},{"key":"10.1053\/j.tcam.2012.08.002_bib74","first-page":"745","article-title":"Clopidogrel therapy in dogs with immune-mediated hemolytic anemia [abstract]","volume":"23","author":"Haviland","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1939-1676.2010.0656.x","article-title":"A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia","volume":"25","author":"Mellett","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1053\/j.tcam.2012.08.002_bib76","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.mjt.0000071284.87458.a4","article-title":"Therapeutics of platelet glycoprotein IIb\/IIIa receptor antagonism","volume":"11","author":"Gowda","year":"2004","journal-title":"Am J Ther"},{"key":"10.1053\/j.tcam.2012.08.002_bib77","series-title":"Platelets","first-page":"1145","article-title":"aIIbB3 (GPIIb-IIIa) Antagonists","author":"Agah","year":"2007"},{"key":"10.1053\/j.tcam.2012.08.002_bib78","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.CIR.95.4.1015","article-title":"Effects of GP IIb\/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis","volume":"95","author":"Makkar","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.tcam.2012.08.002_bib79","first-page":"35","article-title":"Effects of the glycoprotein IIb\/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury","volume":"4","author":"Bright","year":"2003","journal-title":"Vet Ther"},{"key":"10.1053\/j.tcam.2012.08.002_bib80","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1113\/jphysiol.2002.023374","article-title":"Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors","volume":"544","author":"Fu","year":"2002","journal-title":"J Physiol"},{"key":"10.1053\/j.tcam.2012.08.002_bib81","doi-asserted-by":"crossref","first-page":"s39","DOI":"10.1161\/ATVBAHA.107.160226","article-title":"Translational therapeutics of dipyridamole","volume":"28","author":"Kim","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Topics in Companion Animal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1938973612000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1938973612000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:43:05Z","timestamp":1744224185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1938973612000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1938973612000426"],"URL":"https:\/\/doi.org\/10.1053\/j.tcam.2012.08.002","relation":{},"ISSN":["1938-9736"],"issn-type":[{"value":"1938-9736","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}